P784: CYCLOSPORINE WITH THROMBOPOIETIN RECEPTOR AGONIST IN THE TREATMENT OF APLASTIC ANEMIA WITH OR WITHOUT ANTI-THYMOCYTE IMMUNOGLOBULIN：A MULTICENTER REAL WORLD RETROSPECTIVE STUDY

P784: CYCLOSPORINE WITH THROMBOPOIETIN RECEPTOR AGONIST IN THE TREATMENT OF APLASTIC ANEMIA WITH OR WITHOUT ANTI-THYMOCYTE IMMUNOGLOBULIN：A MULTICENTER REAL WORLD RETROSPECTIVE STUDY

Bibliographic Details
Main Authors:	Miao Chen, Bing Han
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970040.32760.b3

Similar Items

An investigation of long-term outcome of rabbit anti-thymocyte globulin and cyclosporine therapy for pediatric severe aplastic anemia
by: Lixian Chang, et al.
Published: (2023-07-01)

High- vs regular-dose recombinant human thrombopoietin plus cyclosporine A in patients with newly diagnosed non-severe aplastic anemia: a retrospective cohort study
by: Yuan Yang, et al.
Published: (2024-12-01)

Aplastic anemia with thrombopoietin gene mutation successfully treated with romiplostim monotherapy
by: Niranjan Gurunath Hegde, et al.
Published: (2023-01-01)

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial
by: Ziqi Wan, et al.
Published: (2023-12-01)

Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
by: Ziqi Wan, et al.
Published: (2023-05-01)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
by: Mengying Zhang, et al.
Published: (2023-09-01)

Gingival and lip hypertrophy induced by cyclosporin A treatment in an aplastic anemia patient
by: Illias Tazi
Published: (2009-06-01)

СIRCULATING SECRETORY IMMUNOGLOBULINA IN SEPTIC DISORDERS
by: N. V. Mal'tseva, et al.
Published: (2018-11-01)

Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity
by: Abhay Singh, et al.
Published: (2015-01-01)

Effects of Cyclosporine and Azacitidine on Some Hematologic and ‎Biochemical Parameters of Benzene-Induced Aplastic Anemia in Rats
by: ghanem taher, et al.
Published: (2023-12-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study
by: Wenrui Yang, et al.
Published: (2023-01-01)

Red blood cell distribution width as a prognostic factor in patients with aplastic anemia treated with cyclosporin A plus androgen or cyclosporine A alone: a retrospective study
by: Xiaotian Zhang, et al.
Published: (2023-12-01)

S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
by: Ashvind Prabahran, et al.
Published: (2023-08-01)

Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia
by: Shanshan Qi, et al.
Published: (2023-12-01)

PB1950: MASS CYTOMETRY ANALYSIS IDENTIFIES T CELL IMMUNE SIGNATURE FOR APLASTIC ANEMIA AND PREDICTS RESPONSE TO CYCLOSPORINE
by: L. Zhang, et al.
Published: (2022-06-01)

P792: CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA
by: Lixian Chang, et al.
Published: (2023-08-01)

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

Detection of platelet-associated immunoglobulins and complement system components in patients with aplastic anemia and hemoblastosis
by: A. F. Rakhmani, et al.
Published: (2019-10-01)

Effect of Thrombopoietin Receptor Agonist on Pregnant Mice
by: Kensaku Nakai, et al.
Published: (2022-02-01)

Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
by: José María Bastida, et al.
Published: (2021-04-01)

ACCELERATED CLEARANCE OF ANTI-THYMOCYTE GLOBULIN IN CHILDREN TRANSPLANTED FOR REFRACTORY CYTOPENIA OF CHILDHOOD VERSUS APLASTIC ANEMIA IS ASSOCIATED WITH INCREASED RISK OF GVHD
by: Eva Koopman-Coenen, et al.
Published: (2023-12-01)

Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience
by: Fergün Yılmaz, et al.
Published: (2021-08-01)

P793: EFFICACY AND IN VIVO EFFECTS OF PORCINE ANTIHUMAN LYMPHOCYTE IMMUNOGLOBULIN COMPARED TO RABBIT ANTITHYMOCYTE IMMUNOGLOBULIN IN SEVERE APLASTIC ANEMIA
by: Guangsheng He, et al.
Published: (2023-08-01)

Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia
by: Jundong Zhang, et al.
Published: (2023-04-01)

Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023-03-01)

Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists
by: Kathy M. Nilles, et al.
Published: (2019-11-01)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
by: Hanny Al-Samkari, et al.
Published: (2019-04-01)

Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01)

Idiopathic Aplastic Anemia: An Update
by: Elena E. Solomou
Published: (2019-03-01)

Use of Cyclosporine A and danazol in treatment of aplastic anemia: A real-world data from a teaching hospital in South India
by: Girish Kamat, et al.
Published: (2022-10-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Knowledge map of thrombopoietin receptor agonists: A bibliometric analysis
by: Rong Hu, et al.
Published: (2024-01-01)

Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
by: Jiwon Shin, et al.
Published: (2023-05-01)

Aplastic anemia in adult and pediatric hematology
by: Charlotte Niemeyer, (Coordinating Author)
Published: (2019-06-01)

Aplastic Anemia in Triple X Syndrome
by: Mohammed Aldarwish, et al.
Published: (2023-01-01)

Aplastic anemia presenting as hemophagocytic lymphohistiocytosis
by: Tiraje Celkan
Published: (2010-03-01)

PB2049: THE EFFICACY OF HETROMBOPAG PLUS CYCLOSPORINE A IN PATIENTS WITH TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY
by: Yuemin Gong, et al.
Published: (2023-08-01)

Cyclosporin A and eltrombopag for aplastic anemia: A promising and cost effective approach: A tertiary care pediatric hematology-oncology centre experience
by: Ritika Khurana, et al.
Published: (2022-01-01)

Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia
by: Rong-Long Chen, et al.
Published: (2022-12-01)